{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T06:00:15Z","timestamp":1790316015056,"version":"4.1.0"},"reference-count":8,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Deutsche Derma Gesell"],"DOI":"10.1111\/ddg.70523","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:39:23Z","timestamp":1790314763000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immune effector cell\u2010associated neurotoxicity syndrome (ICANS) during tebentafusp in metastatic uveal melanoma"],"prefix":"10.1111","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-4198-0836","authenticated-orcid":false,"given":"Laura","family":"Schreieder","sequence":"first","affiliation":[{"name":"Department of Dermatology Regensburg University Hospital  Regensburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Jockel","sequence":"additional","affiliation":[{"name":"Department of Neurology Regensburg University Hospital  Regensburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Zenderowski","sequence":"additional","affiliation":[{"name":"Department of Dermatology Regensburg University Hospital  Regensburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf A.","family":"Linker","sequence":"additional","affiliation":[{"name":"Department of Neurology Regensburg University Hospital  Regensburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Haferkamp","sequence":"additional","affiliation":[{"name":"Department of Dermatology Regensburg University Hospital  Regensburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Bumes","sequence":"additional","affiliation":[{"name":"Department of Neurology Regensburg University Hospital  Regensburg Germany"},{"name":"Wilhelm Sander\u2010NeuroOncology Unit Regensburg University Hospital  Regensburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hau","sequence":"additional","affiliation":[{"name":"Department of Neurology Regensburg University Hospital  Regensburg Germany"},{"name":"Wilhelm Sander\u2010NeuroOncology Unit Regensburg University Hospital  Regensburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin","family":"Drexler","sequence":"additional","affiliation":[{"name":"Department of Dermatology Regensburg University Hospital  Regensburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"issue":"4","key":"e_1_2_4_2_1","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.bbmt.2018.12.758","article-title":"ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells","volume":"25","author":"Lee DW","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"e_1_2_4_3_1","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1080\/14737140.2022.2124971","article-title":"Tebentafusp for the treatment of HLA\u2010A*02:01\u2010positive adult patients with unresectable or metastatic uveal melanoma","volume":"22","author":"Chen LN","year":"2022","journal-title":"Expert Rev Anticancer Ther"},{"issue":"17","key":"e_1_2_4_4_1","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1200\/JCO.21.01805","article-title":"Phase I study of safety, tolerability, and efficacy of tebentafusp using a step\u2010up dosing regimen and expansion in patients with metastatic uveal melanoma","volume":"40","author":"Carvajal RD","year":"2022","journal-title":"J Clin Oncol"},{"key":"e_1_2_4_5_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2023.112986","article-title":"Practical guidelines for the management of adverse events of the T cell engager bispecific tebentafusp","volume":"191","author":"Hassel JC","year":"2023","journal-title":"Eur J Cancer"},{"key":"e_1_2_4_6_1","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/978-3-030-94353-0_27","volume-title":"The EBMT\/EHA CAR\u2010T Cell Handbook","author":"Rees JH","year":"2022"},{"issue":"12","key":"e_1_2_4_7_1","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1158\/2159-8290.CD-17-0698","article-title":"Endothelial activation and blood\u2010brain barrier disruption in neurotoxicity after adoptive immunotherapy with CD19 CAR\u2010T cells","volume":"7","author":"Gust J","year":"2017","journal-title":"Cancer Discov"},{"issue":"7","key":"e_1_2_4_8_1","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41571-024-00903-0","article-title":"Current understanding and management of CAR T cell\u2010associated toxicities","volume":"21","author":"Brudno JN","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"issue":"8","key":"e_1_2_4_9_1","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1158\/2159-8290.CD-17-1319","article-title":"Clinical and biological correlates of neurotoxicity associated with CAR T\u2010cell therapy in patients with B\u2010cell acute lymphoblastic leukemia","volume":"8","author":"Santomasso BD","year":"2018","journal-title":"Cancer Discov"}],"container-title":["JDDG: Journal der Deutschen Dermatologischen Gesellschaft"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ddg.70523","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ddg.70523","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ddg.70523","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:39:24Z","timestamp":1790314764000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ddg.70523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":8,"alternative-id":["10.1111\/ddg.70523"],"URL":"https:\/\/doi.org\/10.1111\/ddg.70523","archive":["Portico"],"relation":{},"ISSN":["1610-0379","1610-0387"],"issn-type":[{"value":"1610-0379","type":"print"},{"value":"1610-0387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]},"assertion":[{"value":"2025-12-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"ddg.70523"}}